Arcadia Biosciences Sales Up 11 Percent

Arcadia Biosciences (NASDAQ:RKDA), a consumer wellness beverage company known for the Zola coconut water brand, released its second quarter results on August 14, 2025. The company reported GAAP revenue of $1.455 million, which was below the $1.60 million analyst estimate (GAAP), and a loss per share of ($3.26) (GAAP), sharply missing the expected (-$0.79 GAAP EPS). The bottom line was heavily impacted by a $4.5 million credit loss related to a note receivable from Above Food Ingredients. While Arcadia's core business showed volume and gross margin improvements, the quarter as a whole was overshadowed by this major non-operating charge and continued transition activity. Source: Analyst estimates for the quarter provided by FactSet. Arcadia Biosciences, once focused on agritech and crop development, is now concentrated on consumer wellness products, with Zola coconut water as its flagship brand. Zola is a ready-to-drink coconut water available in original and flavored varieties and aims to serve the growing segment of consumers seeking health-focused beverages. The company previously earned revenue from crop improvements, patent licensing, and agricultural technology, but has exited these segments to reduce liabilities and sharpen its brand direction.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool